DE602006006875D1 - Verfahren zur inaktivierung von viren durch trockene hitze - Google Patents

Verfahren zur inaktivierung von viren durch trockene hitze

Info

Publication number
DE602006006875D1
DE602006006875D1 DE602006006875T DE602006006875T DE602006006875D1 DE 602006006875 D1 DE602006006875 D1 DE 602006006875D1 DE 602006006875 T DE602006006875 T DE 602006006875T DE 602006006875 T DE602006006875 T DE 602006006875T DE 602006006875 D1 DE602006006875 D1 DE 602006006875D1
Authority
DE
Germany
Prior art keywords
dry heat
inactivating viruses
present
inactivating
viruses
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602006006875T
Other languages
German (de)
English (en)
Inventor
Annie Bardat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
LFB SA
Original Assignee
LFB SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LFB SA filed Critical LFB SA
Publication of DE602006006875D1 publication Critical patent/DE602006006875D1/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A61L2/02—Disinfection or sterilisation of materials or objects, in general; Accessories therefor using physical processes
    • A61L2/04—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Disinfection or sterilisation of materials or objects, in general; Accessories therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2103/00—Materials or objects being the target of disinfection or sterilisation
    • A61L2103/05—Living organisms or biological materials

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
DE602006006875T 2005-12-19 2006-12-19 Verfahren zur inaktivierung von viren durch trockene hitze Active DE602006006875D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0512875A FR2894830B1 (fr) 2005-12-19 2005-12-19 Procede d'inactivation virale par chauffage a sec selon la temperature de transition vitreuse
PCT/FR2006/002817 WO2007071845A2 (fr) 2005-12-19 2006-12-19 Procede d'inactivation virale par chauffage a sec selon la temperature de transition vitreuse

Publications (1)

Publication Number Publication Date
DE602006006875D1 true DE602006006875D1 (de) 2009-06-25

Family

ID=36698885

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602006006875T Active DE602006006875D1 (de) 2005-12-19 2006-12-19 Verfahren zur inaktivierung von viren durch trockene hitze

Country Status (16)

Country Link
US (1) US8252227B2 (https=)
EP (1) EP1981549B1 (https=)
JP (1) JP5085558B2 (https=)
KR (1) KR101162060B1 (https=)
CN (1) CN101355972B (https=)
AT (1) ATE431162T1 (https=)
AU (1) AU2006328804B2 (https=)
BR (1) BRPI0621074B1 (https=)
CA (1) CA2633338C (https=)
DE (1) DE602006006875D1 (https=)
DK (1) DK1981549T3 (https=)
ES (1) ES2327279T3 (https=)
FR (1) FR2894830B1 (https=)
IL (1) IL192194A (https=)
PL (1) PL1981549T3 (https=)
WO (1) WO2007071845A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20140093603A (ko) 2010-12-30 2014-07-28 라보라토이레 프란카이즈 듀 프락티온네먼트 에트 데스 바이오테크놀로지스 병원체 불활성화제로서의 글리콜
USD689039S1 (en) * 2012-07-12 2013-09-03 Alljack Co., Ltd. Stereo set
CN109444209A (zh) * 2018-10-26 2019-03-08 北京食品科学研究院 一种测量蛋清粉玻璃化转变温度的方法
CN116059410A (zh) * 2021-08-19 2023-05-05 南京金斯瑞生物科技有限公司 一种去除生物样本中噬菌体的方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2248817C2 (de) * 1972-10-05 1981-09-24 Bayer Ag, 5090 Leverkusen Polycarbonatmischungen
US4456590B2 (en) * 1981-11-02 1989-05-30 Heat treatment of lyphilized blood clotting factor viii concentrate
GB9424732D0 (en) * 1994-12-08 1995-02-08 Common Services Agency Heat treated blood plasma proteins
US5837519A (en) * 1996-11-21 1998-11-17 Bayer Corporation Dry-heat viral inactivation under controlled moisture conditions
AU9775398A (en) * 1997-09-23 1999-04-12 Ib2, L.L.C. Rapid thermal cycle processing methods and apparatus
CN1286725A (zh) * 1997-11-26 2001-03-07 环球保藏技术股份有限公司 敏感性生物样品的玻化保质法
CA2347242C (en) * 1998-10-14 2008-03-25 Katrina T. Forest Method for vitrification of a biological specimen
CA2396219A1 (en) * 2000-01-04 2001-07-12 Xiangzhong Yang Oocyte vitrification technique
EP1651275A1 (en) * 2003-08-05 2006-05-03 Fuji Photo Film B.V. Use of recombinant or synthetic gelatin-like proteins as stabiliser in lyophilized pharmaceutical compositions

Also Published As

Publication number Publication date
FR2894830B1 (fr) 2008-04-04
US20090297398A1 (en) 2009-12-03
JP2009519920A (ja) 2009-05-21
ES2327279T3 (es) 2009-10-27
IL192194A0 (en) 2009-02-11
DK1981549T3 (da) 2009-08-17
BRPI0621074B1 (pt) 2016-07-26
CA2633338A1 (en) 2007-06-28
EP1981549B1 (fr) 2009-05-13
CN101355972B (zh) 2012-07-04
ATE431162T1 (de) 2009-05-15
WO2007071845A3 (fr) 2007-08-16
KR20080093098A (ko) 2008-10-20
EP1981549A2 (fr) 2008-10-22
US8252227B2 (en) 2012-08-28
PL1981549T3 (pl) 2009-10-30
WO2007071845A2 (fr) 2007-06-28
CN101355972A (zh) 2009-01-28
AU2006328804A1 (en) 2007-06-28
CA2633338C (en) 2012-02-28
AU2006328804B2 (en) 2012-08-02
IL192194A (en) 2010-12-30
BRPI0621074A2 (pt) 2011-11-29
FR2894830A1 (fr) 2007-06-22
KR101162060B1 (ko) 2012-07-03
JP5085558B2 (ja) 2012-11-28

Similar Documents

Publication Publication Date Title
WO2009121004A3 (en) Neutralizing molecules to viral antigens
WO2011015656A3 (en) Composition for treating hbv infection
WO2010047830A3 (en) Agents for hcv treatment
ATE494906T1 (de) Von zellen stammende virale impfstoffe mit geringen mengen an rest-zell-dna
ATE398672T1 (de) Immortalisierte vogelzellinien zur virusproduktion
EA201290152A1 (ru) Антисмысловые ингибиторы вируса гепатита в (hbv)
NO20090447L (no) Hepatittt C virusinhibitorer
NO20081087L (no) Fremgangsmater for fremstilling av sterilisert pankreatinpulver
EA201000948A1 (ru) Ингибиторы вирусной полимеразы
EA200870164A1 (ru) Лечение вирусного гепатита
WO2008033466A3 (en) Compositions and methods for treatment of viral diseases
ATE522532T1 (de) Verbindungen zur behandlung von hepatitis c
IL228065B (en) Live attenuated virus compositions, and methods for decreasing inactivation of live attenuated virus compositions
ATE494291T1 (de) Verbindungen zur behandlung von hepatitis c
WO2009067191A3 (en) Methods and compositions for the treatment of hepatitis c virus (hcv) infection
EE05414B1 (et) Meetod kartuli viirushaigustest tervendamiseks ja parandatud omadustega meristeemkloonide loomiseks, viirusvaba kartuli meristeemtaim ning viirusvaba kartul
WO2010055164A3 (en) Isoquinolone derivatives as inhibitors of plavivirus replication
PH12014500385A1 (en) Benzofuran compounds for the treatment of hepatitis c virus infections
IL192194A (en) Method of viral inactivation by dry heating
WO2013005042A3 (en) Anti-viral therapy
ATE505541T1 (de) Targeting von zwischenprodukten zur gegenstrangreplikation von einzelstrangigen viren durch rnai
MY169510A (en) Detection of epstein -barr virus (ebv) in nasopharyngeal cancer
EP3452595A4 (en) REAGENTS FOR THE TREATMENT OF HEPATITIS B VIRUS (HBV) INFECTION AND USE THEREOF
ATE553770T1 (de) Masernvirus-nucleoprotein zur behandlung von atherosklerose
ATE477807T1 (de) Verwendung einer zusammensetzung zur inhibierung vom viruspartikeln

Legal Events

Date Code Title Description
8364 No opposition during term of opposition